Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity

Published:2021-01-11 Issue:3 Volume:17 Page:259-271
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Alim Karima¹,Bruyère Arnaud¹,Lescoat Alain¹,Jouan Elodie¹,Lecureur Valérie¹,Le Vée Marc¹,Fardel Olivier²

Affiliation:

1. Univ Rennes, Inserm, EHESP, Irset (Institut De Recherche En Santé, Environnement Et Travail) - UMR_S 1085, Rennes, France

2. Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut De Recherche En Santé, Environnement Et Travail) - UMR_S 1085, Rennes, France

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2021.1862084

Reference150 articles.

1. Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

2. JAK inhibitors in 2019, synthetic review in 10 points

3. The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors

4. Signaling through the JAK/STAT pathway, recent advances and future challenges

5. The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic review of janus kinase inhibitors and its clinical implications for the management of rheumatoid arthritis;Expert Opinion on Drug Metabolism & Toxicology;2024-06-26

2. Tofacitinib uptake by patient-derived intestinal organoids predicts individual clinical responsiveness;2024-03-06

3. Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors;American Journal of Clinical Dermatology;2024-01-12

4. High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods;Journal of Biomolecular Structure and Dynamics;2023-08-04

5. Differences in JAK Isoform Selectivity Among Different Types of JAK Inhibitors Evaluated for Rheumatic Diseases Through In Vitro Profiling;Arthritis & Rheumatology;2023-08-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3